-
Mashup Score: 0COVID-19 and Its Impact on Common Diseases in the Allergy Clinics - 6 month(s) ago
Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has various effects on asthma, allergic rhinitis, atopic dermatitis, and urticaria and may change the course of the disease depending on the severity of the infection and control status of the disease. Conversely, these diseases may also impact the course of COVID-19. Patients with chronic urticaria and atopic dermatitis may have COVID-19–induced disease exacerbations and biological treatments reduce the risk of exacerbations.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Cockroach, dust mite, cat, dog, mouse, and molds are major indoor allergens that have been associated with the development of allergic diseases and disease morbidity in allergen-sensitized individuals. Physical characteristics, such as allergen particle size, hydrophobicity, and charge, can determine an allergen’s propensity to become airborne, location of respiratory tract penetration, and ability to elicit IgE responses in genetically predisposed individuals. Standardization and recent advancements in indoor allergen assessment serve to identify sources and distribution of allergens in a patient’s home and public environment, inform public policy, and monitor the efficacy of allergen avoidance and therapeutics.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 5Unraveling the Complex Web of Protein Interactions in Diseases - 8 month(s) ago
A powerful technique promises to provide new insights into the roles that dysregulated protein interactions play in diseases
Source: www.scientificamerican.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis’ lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value? - 11 month(s) ago
Hospitals in England experience extremely high levels of bed occupancy in the winter. In these circumstances, vaccine-preventable hospitalisations due to seasonal respiratory infections have a high cost because of the missed opportunity to treat other patients on the waiting list. This paper estimates the number of hospitalisations that current vaccines against influenza, pneumococcal disease…
Source: MDPICategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
Background Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms, cardiometabolic diseases, and quality of life (QoL) is unknown. Methods Using data from the Burden of Obstructive Lung Disease study (N = 21,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the…
Source: BioMed CentralCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies - 11 month(s) ago
Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute exacerbation of COPD (AECOPD), compared with a non-exacerbation period. While the effect of severe AECOPD is well established, the relationship of moderate exacerbation or prior exacerbation to elevated risk of…
Source: BMJ OpenCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population - 11 month(s) ago
AbstractAims. Inflammatory bowel disease (IBD) is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). We compared cardiovascula
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360 BioPharma Research System - 12 month(s) ago
May 15, 2023 — Cardio Diagnostics Holdings, Inc, a precision cardiovascular medicine company, today announced the availability of its CardioInnovate360 research-use-only (RUO) solution for biopharmaceutical companies that have and/or are developing therapeutics for cardiovascular disease (CVD) conditions or associated co-morbidities. According to Precedence Research, the global cardiovascular…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Summary. Large hiatus hernias with a significant paraesophageal component (types II–IV) have a range of insidious symptoms. Management of symptomatic hernias in
Source: OUP AcademicCategories: Healthcare Professionals, Latest HeadlinesTweet
In Press! #COVID19 and Its #Impact on Common #Diseases in the #Allergy #Clinics #JACIIPCOVID https://t.co/eE5siib12c